Literature DB >> 7776682

Pulmonary resection for invasive Aspergillus infections in immunocompromised patients.

L A Robinson1, E C Reed, T A Galbraith, A Alonso, A L Moulton, W H Fleming.   

Abstract

Standard antifungal medical therapy of invasive pulmonary aspergillosis that occurs in immunocompromised patients with hematologic diseases with neutropenia or in liver transplant recipients results in less than a 5% survival. In view of these dismal mortality rates, we adopted an aggressive approach with resection of the involved area of lung along with systemic antifungal therapy when localized invasive pulmonary aspergillosis developed in these patients. Between January 1987 and December 1993, 14 patients with hematologic diseases and 2 liver transplant recipients underwent resection of acute localized pulmonary masses suggestive of invasive pulmonary aspergillosis a median of 7.5 days (range 1 to 45 days) after the diagnosis was clinically suggested and confirmed by chest computed tomographic scans. Operative procedures done included two pneumonectomies, one bilobectomy with limited thoracoplasty, nine lobectomies, and five wedge resections (one patient with hematologic disease had two procedures). All patients were treated before and after the operation with antifungal agents. Nine (64%) of 14 patients with hematologic disease and 2 (100%) of 2 liver transplant recipients survived the hospitalization with no evidence of recurrent Aspergillus infection after a median 8 months of follow-up (range 3 to 82 months). The five hospital deaths (all patients with hematologic diseases) occurred a median of 20 days after operation from diffuse alveolar hemorrhage in three, graft-versus-host disease in one, and multiple organ system failure with presumed disseminated Aspergillus infection in one. Four of the five deaths were in patients with allogeneic bone marrow transplants. Two of the three patients requiring resection of multiple foci of infection died, as did the only patient who was preoperatively ventilator dependent. In immunocompromised patients with hematologic diseases or liver transplantation with invasive pulmonary aspergillosis, early pulmonary resection should be strongly considered when the characteristic clinical and radiographic pictures appear.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776682     DOI: 10.1016/S0022-5223(95)70202-4

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

Review 1.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR.

Authors:  H Skladny; D Buchheidt; C Baust; F Krieg-Schneider; W Seifarth; C Leib-Mösch; R Hehlmann
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 3.  Aspergillosis in the ICU: the glass half-empty?

Authors:  S W Crawford
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

4.  Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy.

Authors:  Katsuyuki Asai; Kazuya Suzuki; Tsuyoshi Takahashi; Yasushi Ito; Teruhisa Kazui; Yusuke Kita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-04

5.  Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation.

Authors:  P C Iwen; M E Rupp; M R Bishop; M G Rinaldi; D A Sutton; S Tarantolo; S H Hinrichs
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

6.  Biodiversity and concentration of airborne fungi in a hospital environment.

Authors:  J Rainer; U Peintner; R Pöder
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

7.  Surgery of pulmonary aspergillomas in immunocompromised patients.

Authors:  B Kosan; V Steger; T Walker; G Friedel; H Aebert
Journal:  Thorac Surg Sci       Date:  2010-03-10

8.  Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample.

Authors:  Deven C Patel; Prasha Bhandari; David J Epstein; Douglas Z Liou; Leah M Backhus; Mark F Berry; Joseph B Shrager; Natalie S Lui
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

9.  [Evolution of postoperative sequelae of pulmonary tuberculosis in HIV seropositive].

Authors:  Ayegnon Kouakou Grégoire; Kendja Hypolite Flavien; Ouédé Raphaël; Blaise Démine; Ménéas Gueu Christophe; Ano Kounangui Marie; Yangni-Angaté Koffi Hervé; Tanauh Yves
Journal:  Pan Afr Med J       Date:  2014-01-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.